OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating comparable ...

Nalagenetics, a spin-off from A*STAR GIS, will be implementing a nationwide genetic screening programme in Indonesia with their PGx1301 diagnostic kit for leprosy patients. Set to launch in the fourth ...

A new study reveals that generic drugs manufactured in India have a higher association with severe adverse events such as hospitalization, disability, and death compared to those made in the U.S ...

Generic drugs manufactured in India are linked to significantly more “severe adverse events” for patients who use them than equivalent drugs produced in the United States, a new study finds. These ...

A new study has found that generic drugs manufactured in India are linked to significantly more severe adverse events — including hospitalization, disability and in some cases death — compared ...

Concomitant health products (exclude treatment of action): other health products that were used at the same time as the adverse reaction describe if any drugs or health products are also suspected in ...

FDA proposes draft guidelines on AI use in drug development, addressing challenges and opportunities for improving safety and efficacy.

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro ...

But things took an awful turn when his character Nathan Williams stood up for his son Johnny [Louis Ashbourne Serkis] after the teen thought the drugs he ... who was not adverse to the odd illegal ...

Chelsea forward Mykhailo Mudryk has been provisionally suspended by the Football Association after failing a drugs test ... concerning an adverse finding in a routine urine test.

Further research is warranted to understand the clinical impact of these changes. The Immune-Mediated Adverse Drug Reactions (IMARI) Registry and Biorepository is the first multidisciplinary drug ...